Undisclosed TriNKETs / Dragonfly Therap - LARVOL DELTA

Dragonfly Therapeutics Announces First Patient Dosed in Clinical Trial Evaluating Solid Tumor Targeting TriNKET Conducted by Merck (PRNewswire) - "Dragonfly Therapeutics, Inc....announced that the first patient has been dosed in a clinical trial being conducted by Merck, known as MSD outside the United States and Canada, to evaluate a solid tumor targeting TriNKET developed by Dragonfly. Dragonfly will receive an undisclosed milestone payment triggered by this event."

Trial status • Oncology • Solid Tumor